1. Introduction {#s0005}
===============

Major depressive disorder (MDD) is a leading cause of disability ([@bb0140]). Amongst adolescents, point prevalence is 6--9% ([@bb0110]), with a 25% lifetime prevalence by the end of adolescence ([@bb0080]). Depressed adolescents demonstrate concurrent functional impairments in cognitive and social areas, and high rates of personality disorders, suicide, self-harm, and substance abuse ([@bb0060]). Around 33% of diagnosed adult cases originate in adolescence ([@bb0030]). MDD can arise during adolescence from psychosocial stress factors, differences in epigenetic and genetic susceptibilities, and glucocorticoid vulnerabilities that lead separately or in combination to imbalances between bottom-up emotional ('hot') processing and top-down cognitive ('cold') processing, triggering lasting alterations in brain maturation trajectories ([@bb0055]).

Blood oxygenation level dependent (BOLD) sensitive functional magnetic resonance imaging (fMRI) acquired during stimuli-free acquisition is the basis for constructing resting state functional connectivity (rsFC) networks of synchronous, spontaneous brain activity. Evidence from fMRI in depressed adults provides strong support for disruption of the fronto-limbic system, a key component of the 'hot' emotional processing system ([@bb0010]). However, the ACC has also been implicated in 'cold' cognition ([@bb0115]). Specifically, MDD is associated with dysfunction of the anterior cingulate cortex (ACC)-pallidostriatal-thalamic-amygdala circuit, which forms part of the cortico-limbic mood-regulating circuit ([@bb0010]), with increased subgenual ACC (sgACC)-default mode network (DMN) and thalamus-DMN rsFC in patients ([@bb0040]). Adolescent patients also demonstrate increased sgACC-insula, and sgACC-amygdala rsFC ([@bb0020]).

A corresponding decrease in areas involved in 'cold' cognitive control, such as the PFC, is seen in adult patients ([@bb0005]). Reduced rsFC has also been detected in the ACC, insula, amygdala, and frontal pole ([@bb0135]). Whether these connectivity findings are present in adolescents with MDD is less clear, although adolescent patients have exhibited decreased rsFC between sgACC and supragenual ACC, insula, and parts of the frontal and temporal cortices ([@bb0025]). Given that diagnostic characteristics are the same across all ages, we hypothesise that these findings will be replicated in this young age range prior to treatment.

National Institute for Health and Care Excellence (NICE) guidelines in the United Kingdom for the treatment of depression in adolescence recommend psychological therapies such as cognitive behavioral therapy (CBT) as first-line treatment, with or without the antidepressant fluoxetine ([@bb0095]). There is evidence from imaging that either treatment is associated with restoring fronto-limbic connectivity in adults ([@bb0045]).

This study is an analysis of rsFC in adolescent patients with MDD enrolled in the Improving Mood with Psychoanalytic and Cognitive Therapies (IMPACT) clinical trial ([@bb0030]). As MDD is associated with pathological increases in physiological activity in regions of 'hot' emotional processing, and reduced in activity in regions of 'cold' cognitive control, we hypothesized that, prior to treatment with CBT, adolescent MDD patients would show hyper-connectivity in limbic structures and hypo-connectivity in regions connected to the pre-frontal cortex. We further hypothesized that CBT would be associated with normalising rsFC patterns in patients towards those seen in controls. Ameliorating aberrant connectivity associated with depressive illness early in the course of the disorder may pre-empt more atypical developmental changes to brain structure and related functions, thereby reducing the risk of recurrence and relapse.

2. Materials and Methods {#s0010}
========================

2.1. Participants {#s0015}
-----------------

The IMPACT trial was a pragmatic, single-blind, randomized controlled trial with the primary hypothesis that specialised psychological treatments had more enduring clinical effects in maintaining reduced depression symptoms compared with specialist clinical care ([@bb0030]). Enrolled patients from 16 Child and Adolescent Mental Health Services (CAMHS) clinics in the UK satisfied DSM-IV criteria for unipolar MDD.

The MR-IMPACT study recruited IMPACT participants from East Anglia and North London, and conducted an MRI assessment prior to randomisation ([@bb0050]). Those randomized to CBT were invited to return for a second MRI assessment following completion of their treatment around 24 weeks later (Range of follow-up time for patients: 17.14--51 weeks, standard deviation: 9.27). To be eligible for the post-treatment assessment, participants should have attended at least 6 out of 20 scheduled appointments: median number attended was 8, with a mean interval of 16 days between sessions. Control participants were recruited from local schools and screened for the absence of current depressive illness by requiring a score ≤ 5 on the self-report Short Moods and Feelings Questionnaire (SMFQ) ([@bb0120]). Two MRI assessments were scheduled 24 weeks apart.

The State-Trait Anxiety Inventory (STAI) scale was used to assess current anxiety state using STAI-S and long-term anxiety trait with STAI-T at both MRI assessments ([@bb0125]), with higher scores indicating greater anxiety levels. Exclusion criteria for all participants included: alcohol or drug dependence, generalized learning problems, pregnancy or breastfeeding, concurrent medication use that could adversely interact with SSRIs (patients only), and MRI contraindications ([@bb0050]). Participants and their families gave signed informed consent. Ethical approval was provided by the Cambridgeshire 2 Research Ethics Committee (Reference: 09-H0308-168), following the Declaration of Helsinki.

In total, 168 participants 11--17 years old were enrolled into MR-IMPACT: 128 patients (34 males, 94 females) and 40 controls (11 males, 29 females). From these, 108 patients undertook only the pre-treatment (baseline) MRI assessment, of which 26 were excluded, along with 6 controls. Reasons for exclusion are shown in Fig. S1. Thus, 82 patients (18 males, 64 females) and 34 healthy controls (7 males, 27 females) were used for case-control comparisons: this was the *cross-sectional sample* ([Table 1](#t0005){ref-type="table"}).

The 20 remaining patients had both baseline and post-treatment (follow-up) MRI assessments, with 3 excluded (Fig. S1). 33 controls had scans separated by a similar interval, of which 3 were excluded (Fig. S1), leaving 17 patients and 30 controls in the *longitudinal sample* ([Table 2](#t0010){ref-type="table"}). The independence of the patients in the cross-sectional and longitudinal samples is an important feature of the analysis strategy; the *cross-sectional sample* findings were used as a mask for the *longitudinal sample* analyses.

2.2. MRI Acquisition and Processing {#s0020}
-----------------------------------

MRI scanning took place on a Siemens 3T Trim Trio scanner at the Wolfson Brain Imaging Centre, University of Cambridge, UK. BOLD-sensitive echo-planar images (EPI) were acquired at baseline and follow-up assessments, whilst participants lay awake with eyes closed. EPI scans were 8 min 56 s long with 256 whole-brain images collected. Experimental details were previously published ([@bb0050]).

EPI images were processed to correct for head motion during acquisition using the speedypp algorithm from the BrainWavelet Toolbox (BWT) ([www.brainwavelet.org](http://www.brainwavelet.org){#ir0005}), according to the established protocol ([@bb0100]). All data were non-linearly transformed to the standard stereotactic space of the MNI152 template using the Advanced Normalisation Tools (ANTs) ([@bb0015]). Once processed, images were overlaid with the Automated Anatomical Labelling (AAL) atlas defining 116 regions of interest (ROIs) ([@bb0130]).

Mean DVARS, the average root-mean-square variance across all brain voxels of volume-to-volume difference in percent BOLD signal change, and translations and rotations about orthogonal axes were used to test for between-group differences in head motion using *t*-tests (assuming unequal variances). Eight participants were excluded as their variation of motion exceeded the range − 2 \> mean DVARS \> 2 ([@bb0100]).

2.3. Functional Connectivity in 'Hot' and 'Cold' Systems {#s0025}
--------------------------------------------------------

Based on previously reported fronto-limbic alterations in depression, amygdala and ACC regions of the AAL atlas were chosen as seed regions to investigate case-control differences in rsFC with the *cross-sectional sample*, as they are those associated with the 'hot' emotional system. Bilateral PFC regions corresponding to Brodmann area 9 were chosen as seed regions indicative of the 'cold' cognitive system ([Fig. 1](#f0005){ref-type="fig"}), based on previous studies ([@bb0085]). MDD has been associated with specific parts of the ACC ([@bb0020], [@bb0025]), therefore the ACC was sub-divided into subgenual and supragenual regions, superior and inferior to the line connecting the frontal pole to the genu of the corpus callosum, respectively.

For each seed region separately, using FMRIB\'s Software Library\'s (FSL\'s) FMRI Expert Analysis Tool (FEAT) tool ([www.fmrib.ox.ac.uk)](http://www.fmrib.ox.ac.uk)){#ir0010}, a univariate general linear model (GLM) was regressed at each intracerebral voxel, with the average time-series of the seed region as the independent variable and the voxel time-series as the dependent variable, to estimate rsFC with the corresponding *Z*-statistic. Between-group differences in rsFC of the *cross-sectional sample* were tested by GLM across the entire brain parenchyma. For seed regions associated with significant between-group effects, the effect of CBT on the rsFC in the *longitudinal sample* was assessed across the whole-brain by a group (patients and controls) by time (baseline and 24-week scan) interaction, which was interpreted as the treatment effect, using a two-way mixed effects GLM.

Age and gender were included as covariates in all models. All image-based statistical inference was undertaken with the FEAT or FMRIB\'s Local Analysis of Mixed Effects (FLAME) software on spatially extended statistics with a cluster-forming voxel threshold of z \> 2.3 followed by a family-wise error rate (FWER)-corrected cluster significance threshold of *p* \< 0.05.([@bb0145]) Significant interactions were examined graphically to determine their direction.

2.4. Relationship of Connectivity to Symptoms {#s0030}
---------------------------------------------

Within brain areas demonstrating significant between-group effects in the *cross-sectional sample*, the relationship of rsFC to SMFQ, STAI-S, and STAI-T was tested in separate GLMs. The relationship between the change in mean rsFC and change in symptom scores (SMFQ) relative to baseline SMFQ was tested in areas demonstrating treatment effects in the *longitudinal sample*.

Statistical analyses were conducted in R (version 3.3.0). The threshold for significance was *p* \< 0.05.

2.5. Cross-sectional Sample: Demographics {#s0035}
-----------------------------------------

Patient (N = 82) and control (N = 34) participants did not differ significantly in age (t(50.32) = − 0.16, *p* = 0.88), gender (χ~1~^2^ = 0.03, *p* = 0.87), handedness (t(68.51) = − 1.44, *p* = 0.15), or IQ (t(32.28) = − 1.09, *p* = 0.28). As expected, SMFQ, STAI-S, and STAI-T scores were significantly higher for the depressed participants (*p* \< 0.0001). Full details are given in [Table 1](#t0005){ref-type="table"}, and medication status of patients in Table S1A.

2.6. Cross-sectional Sample: Between-group Differences in rsFC {#s0040}
--------------------------------------------------------------

Significant between-group differences in mean DVARS and rotation about the z-axis were found (Table S2A), although effective correction for these effects was applied during preprocessing ([@bb0100]).

No significant between-group differences were observed in rsFC to the right amygdala, bilateral sgACC, and bilateral PFC seed regions.

Patients exhibited greater rsFC between the left amygdala seed region and the insula, supragenual ACC, thalamus, hippocampus, right amygdala, right parietal areas, right angular and lingual gyri, right putamen, precuneus, and right PCC ([Fig. 2](#f0010){ref-type="fig"}, Table S3). Patients also exhibited greater rsFC between the left supragenual ACC seed region and the right planum temporale, right parietal operculum, right post-central gyrus, right PCC, left thalamus, and bilateral insula ([Fig. 2](#f0010){ref-type="fig"}, Table S3), as well as between the right supragenual ACC seed region in the right pre-central gyrus, supramarginal gyrus, frontal pole, insula, bilateral post-central gyrus, and superior temporal gyrus ([Fig. 2](#f0010){ref-type="fig"}, Table S3).

2.7. Cross-sectional Sample: Relationships to Symptoms {#s0045}
------------------------------------------------------

For depressed adolescents, there were no significant relationships between rsFC in regions demonstrating a between-group difference to any seed region and symptoms measured with SMFQ, STAI-S, or STAI-T.

2.8. Longitudinal Sample: Demographics {#s0050}
--------------------------------------

Patients (N = 17) in the *longitudinal sample* were not included in the *cross-sectional sample*, although controls (N = 30) were drawn from the same individuals. The longitudinal patient samples did not differ on age (t(35.83) = − 0.40, *p* = 0.70), gender (χ~1~^2^ = 0.04, *p* = 0.84), handedness (t(41.11) = − 0.06, *p* = 0.95), or IQ (t(4.83) = − 0.45, *p* = 0.67) compared to controls ([Table 2](#t0010){ref-type="table"}). As anticipated, SMFQ, STAI-S, and STAI-T scores were significantly higher for patients ([Table 2](#t0010){ref-type="table"}). Medication status is given in Table S1B. There were no significant differences in demographics and symptoms between patients in the cross-sectional and longitudinal samples (t(25.99) = − 0·04, *p* = 0.97).

2.9. Longitudinal Sample: Treatment Effects {#s0055}
-------------------------------------------

Connectivity estimates associated with seed regions where between-group effects were seen (i.e., left and right supragenual ACC, left amygdala), were tested for treatment effects across the entire parenchyma in the *longitudinal sample*. There were no significant treatment effects in regions connected to left amygdala or right supragenual ACC. However, significant effects of treatment were seen with rsFC to the left supragenual ACC seed in right insula (F(1, 43) = 5.28; *p* = 0.02) ([Fig. 3](#f0015){ref-type="fig"}). rsFC in both patients and controls was increased in the post-CBT scan. Post-hoc tests of between-group effects in the *longitudinal sample* indicates that the significant between-group effect at baseline (F(1, 43) = 6.92; *p* = 0.01) was significantly different from the between-group difference following CBT (F(1, 43) = 1.05; *p* = 0.31).

2.10. Longitudinal sample: Relationships to Symptom Change {#s0060}
----------------------------------------------------------

Patients in the *longitudinal sample* demonstrated a significant reduction in symptom severity after receiving CBT: baseline, mean SMFQ = 16.71 ± 4.90; post-treatment, mean SMFQ = 8.88 ± 5.12 (F(1, 30) = 21.18; *p* = 7.14 × 10^− 5^). In regions showing significant treatment effects with the left supragenual ACC seed, there was also a significant relationship between changes in rsFC and changes in SMFQ post-treatment, relative to baseline SMFQ values (F(1, 13) = 5.44, *p* = 0.04, effect size = 0.52) ([Fig. 3](#f0015){ref-type="fig"}B), as well as STAI-T (F(1, 13) = 5.26, *p* = 0.04, effect size = 0.51), but non-significant when related to STAI-S (F(1, 13) = 0.11, *p* = 0.77, effect size = 0.08).

3. Discussion {#s0065}
=============

This study investigates the effect of treatment on rsFC in neural regions indexing the 'hot' emotional, and 'cold' cognitive systems in adolescents with MDD. As hypothesized, depressed adolescents had increased rsFC of parts of the 'hot' limbic system relative to controls. However, no difference was found with connectivity to the 'cold' PFC. These results suggest a specific pathology to the limbic system following the onset of symptoms. Whether this represents an illness-related effect or a putative marker prior to illness emergence cannot be determined from these cross-sectional findings. Evidence of such abnormalities has been found in high-risk individuals. Hyper-connectivity in left temporal cortex, insula, ACC, medial orbitofrontal PFC, and ventromedial PFC was observed in 6-month-old infants born to mothers with prenatal maternal depressive symptoms, similar to patterns observed in depressed adolescents and adults ([@bb0105]). Development of 'hot' emotional processing and 'cold' cognitive processing systems may occur at different rates during adolescence, and asynchronous trajectories may have adverse consequences for mental health and contribute to the emergence of MDD ([@bb0055]). In this study, elevated rsFC of the 'hot' (limbic) system in the absence of differences in the 'cold' (pre-frontal) system implies that depressive symptoms may emerge from physiologically overactive bottom-up cortical regions with a loss of influence from their top-down counterparts.

Our study is aligned with previous research on adults with depression showing altered rsFC in areas which may be critical for mood regulation ([@bb0005]). The right insula exhibited significantly greater connectivity with left amygdala and bilateral supragenual ACC seed regions. Altered insular rsFC has been shown in depressed adolescents and adults ([@bb0020], [@bb0135]. The right anterior insula may play a role in adaptively switching from rumination to interoceptive awareness ([@bb0070]). Hyper-connectivity between the ACC and insula has proved to be more equivocal in adolescents; both elevated and reduced rsFC to the subgenual ACC and the insula have been reported ([@bb0020], [@bb0025]). Such differences may reflect variation in experimental details, or in sample characteristics, such as medication use. Here, 30 of 82 patients were medicated. However, comparing only those on medication to controls (Fig. S5) or medication-naïve to controls (Fig. S4) led to similar patterns of increased rsFC to left amygdala and bilateral supragenual ACC compared to healthy controls. Length of time on medication may also be a factor, but was not available.

Early life stress has been associated with markedly elevated rates of MDD in child, adolescent, and adult cohorts, and may therefore affect brain function, leading to observable differences in rsFC prior to onset of a first episode ([@bb0065]).

All patients had improved symptoms following CBT. Successful treatment was associated with normalisation of rsFC ([Fig. 3](#f0015){ref-type="fig"}). The sensitivity of this change in right insula was corroborated by a normalisation of rsFC along with a reduction in symptoms scores; larger alterations in rsFC led to reductions in symptoms ([Fig. 3](#f0015){ref-type="fig"}B). Changes in insula activity have been shown to take place following various treatments, including medication, deep brain stimulation, vagus nerve stimulation, and mindfulness training, indicating a role for this region in mediating treatment response ([@bb0090]). This suggests that cognitive mechanisms involved in recovery involve the inhibition of pathological rumination and the re-instigation of interoceptive processing and monitoring of bottom-up physiological signals. Significant time effects were observed for all seed regions which did not overlap with treatment effects. These may reflect maturation changes with time or accommodation of participants to the MRI environment, or both.

The significant baseline group differences in rsFC and treatment effects observed are in adjacent, but distinct areas of the right insula. This may be due to a reduction in power in the longitudinal analysis, or that regions with small baseline differences, undetectable in a whole-brain analysis after appropriate multiple comparisons correction, are more amenable to CBT; that is, only areas of the limbic system that are not extensively damaged are recoverable.

These findings must be interpreted with limitations in mind. The study was a parallel group, longitudinal design typical for assessing treatment effects. However, the control group were healthy adolescents rather than patients randomized to placebo, due to ethical concerns of withholding treatment and the difficulty of providing a placebo conversational therapy. Therefore, we cannot conclude whether improvements were due to CBT or non-specific effects of improvement in symptoms. Patients were recruited from the IMPACT effectiveness trial with potential participants approached sequentially in clinical settings. The sample thus reflects the local patient population, subject to biases in consenting. Male participants constituted around 25% (25/91), which differs from the 2:1 female:male ratio more widely observed in adolescents with depression ([@bb9000]). Furthermore, the follow-up patient sample was limited in size.

The 11--17 years age range covers the period during which brain maturation is significant. As treatment effects were the focus of the study, effects of age and gender, although modelled, were not investigated here. There were no significant demographic differences between groups. Significant between-group differences in some head motion parameters were found. Hence, motion cannot be completely ruled out as a source of between-group rsFC differences. However, in a comparison of a subset of participants with no significant between-group difference in DVARS, patterns of increased rsFC in the limbic system were sustained (Fig. S3).

In summary, this study investigated rsFC differences in adolescents with MDD compared to healthy controls. Depressed adolescents demonstrated greater rsFC in limbic regions associated with 'hot' emotional processing in the absence of differences in regions associated with 'cold' cognition; that is, an imbalance between these systems. This is possibly due to the relative speeds of maturation of the two systems ([@bb0055]). Coupled with similar results from elsewhere, rsFC is a potential marker for MDD in adolescence. Neurobiologically, CBT normalized aberrant rsFC patterns in the limbic system of adolescents with MDD. Symptom recovery may at least in part be associated with a 'cooling' of 'hot' emotional brain systems, and their restoration is a key component of the mechanism of action of therapeutic interventions, such as CBT.
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![Seed regions investigated in the study. The amygdala, ACC, and PFC regions of the AAL atlas were chosen as seed regions based on previous literature to investigate case-control differences in rsFC.](gr1){#f0005}

![Significant case-control differences (MDD \> Controls) in rsFC to the left amygdala, left supragenual ACC and right supragenual ACC seed regions respectively were found for the *cross-sectional sample* before patients with MDD underwent cognitive behavioral therapy (CBT) sessions (N = 116, *p* \< 0.05).\
A: Left Amygdala seed; B: Left Supragenual ACC seed, C: Right Supragenual ACC seed.](gr2){#f0010}

![a. Treatment effects seen with left supragenual ACC seed in right insula in the *longitudinal sample*. b. Significant relationship between change in SMFQ vs change in rsFC (relative to baseline SMFQ) to left supragenual ACC seed was noted in the patient group (F(1, 13) = 5.44, *p* = 0.04).](gr3){#f0015}

###### 

Demographic and clinical characteristics of depressed and healthy adolescents from the *cross-sectional sample* (N = 116).

Table 1

  -----------------------------------------------------------------------------------------------------------------------------
  Characteristic                                     MDD adolescents\   Control adolescents\   *p*-value\
                                                     n = 82\            n = 34\                (*p* \< 0.05 for significance)
                                                     Mean (SD)          Mean (SD)              
  -------------------------------------------------- ------------------ ---------------------- --------------------------------
  Age (years)                                        15.69 (1.12)       15.73 (1.44)           0.875

  Range                                              13.48--17.96       12.14--17.73           

  Gender (Male/Female)                               18/64              7/27                   0.871

  Handedness (Edinburgh Handedness Inventory (46))   54.51 (58.84)      70.56 (52.67)          0.154

  IQ (from 17 patients, 34 controls)                 97.35 (10·73)      100.82 (10.79)         0.285

  SMFQ score                                         18.02 (4.89)       2.65 (1.97)            *p* \< 0.0001

  STAI State score                                   45.95 (10.00)      28.82 (6.76)           *p* \< 0.0001

  STAI Trait score                                   59.78 (8.02)       30.59 (6.58)           *p* \< 0.0001
  -----------------------------------------------------------------------------------------------------------------------------

###### 

Demographic and clinical characteristics of the depressed and healthy adolescent participants from the *longitudinal sample* (N = 47).

Table 2

  -----------------------------------------------------------------------------------------------------------------------------
  Characteristic                                     MDD adolescents\   Control adolescents\   *p*-Value\
                                                     n = 17\            n = 30\                (*p* \< 0.05 for significance)
                                                     Mean (SD)          Mean (SD)              
  -------------------------------------------------- ------------------ ---------------------- --------------------------------
  Age at first scan (years)                          15.42 (1.37)       15.59 (1.47)           0.690

  Range                                              12.89--17.56       12.14--17.73           

  Age at second scan (years)                         16.07 (1.34)       16.24 (1.46)           0.695

  Range                                              13.41--18.17       12.92--18.30           

  Gender (Male/Female)                               3/14               6/24                   0.844

  Handedness (Edinburgh Handedness Inventory (46))   66.47 (41.82)      67.30 (55.26)          0.954

  IQ (from 5 patients, 30 controls)                  98.60 (14.40)      101.67 (11.15)         0.669

  SMFQ score at first scan                           16.71 (4.90)       2.57 (1.81)            7.46 × 10\^− 10

  SMFQ score at second scan                          8.88 (5.12)        2.37 (1.85)            7.62 × 10\^− 5

  STAI State score at first scan                     48.24 (11.33)      28.90 (6.91)           1.63 × 10\^− 6

  STAI State score at second scan                    35.59 (10.13)      26.10 (10.48)          0.002

  STAI Trait score at first scan                     61.94 (9.08)       30.50 (6.91)           1.44 × 10\^− 12

  STAI Trait score at second scan                    44.12 (10.48)      28.37 (6.49)           1.00 × 10\^− 5
  -----------------------------------------------------------------------------------------------------------------------------
